Related Experiment Video
Updated: May 29, 2026

Culturing Primary Rat Inner Medullary Collecting Duct Cells
Published on: June 21, 2013
Functional characterization of novel loss-of-function mutations in the vasopressin type 2 receptor gene causing
Iris Böselt1, Despoina Tramma, Serafia Kalamitsou
1Molecular Biochemistry, Institute of Biochemistry, Medical Faculty, University of Leipzig, Leipzig, Germany.
Background:
X-linked nephrogenic diabetes insipidus (NDI) is a rare polyuric disorder caused by inactivating mutations in the arginine vasopressin receptor Type 2 (AVPR2) gene.
Methods:
NDI patients from six unrelated families were subjected to mutational analysis of the AVPR2 gene. In-depth in vitro characterization of novel AVPR2 mutants by a combination of functional and immunological techniques provided further insight into molecular mechanisms causing receptor dysfunction.
Results:
Mutational analysis revealed four novel (A89P, G107R, Q174R, W208X) and three recurrent (V277A, R337X, ΔR247-G250) mutations within the AVPR2 gene. One family carried the missense mutation R337X and a 12-bp deletion (ΔR247-G250), corresponding to a fragment in the third intracellular loop (ICL3), which was not genetically linked to R337X. The functionally tested missense mutations A89P, G107R and Q174R led to reduced receptor cell surface expression in transfected COS-7 cells, most probably due to misfolding and intracellular retention, and consequently to reduction or loss of agonist-mediated cyclic adenosine monophosphate formation. Deletion of R247-G250 had no effect on receptor function in vitro. Comparison with other mammalian AVPR2 orthologs showed that this part of the ICL3 is structurally not conserved and, therefore, less relevant for receptor function. In contrast, all missense mutations (A89P, G107R, Q174R, V277A) affect receptor positions that were fully preserved during mammalian evolution.
Conclusion:
Our results provide valuable information about residues critical for AVPR2 folding, trafficking and function and proof that these mutations are responsible for causing NDI in the affected subjects.
Insights
X-linked nephrogenic diabetes insipidus (NDI) results from AVPR2 gene mutations. Novel mutations identified cause receptor dysfunction by impairing folding and cell surface expression, leading to NDI in patients.
Area of Science:
- Genetics
- Molecular Biology
- Endocrinology
Background:
- X-linked nephrogenic diabetes insipidus (NDI) is a rare disorder characterized by polyuria.
- It is caused by inactivating mutations in the arginine vasopressin receptor Type 2 (AVPR2) gene.
Purpose of the Study:
- To identify and characterize novel mutations in the AVPR2 gene in NDI patients.
- To elucidate the molecular mechanisms underlying AVPR2 receptor dysfunction.
Main Methods:
- Mutational analysis of the AVPR2 gene in NDI patients from six families.
- In vitro functional and immunological characterization of novel AVPR2 mutants using COS-7 cells.
Main Results:
- Four novel (A89P, G107R, Q174R, W208X) and three recurrent (V277A, R337X, ΔR247-G250) AVPR2 mutations were identified.
- Missense mutations (A89P, G107R, Q174R, V277A) impaired receptor cell surface expression and function, likely due to misfolding and intracellular retention.
- A deletion in the third intracellular loop (ΔR247-G250) did not affect receptor function in vitro.
Conclusions:
- Identified AVPR2 mutations are responsible for causing NDI in affected individuals.
- Specific residues are critical for AVPR2 folding, trafficking, and function.
More Related Videos
08:46Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Diabetes Insipidus II: Pathophysiology
Diabetes Insipidus I: Introduction
Diabetic Nephropathy
Type II Diabetes I: Introduction
Aquaporins
Antihypertensive Drugs: Potassium-Sparing Diuretics